SUBSTRATE INTERACTIONS OF A MULTIFUNCTIONAL INTEGRASE
多功能整合酶的底物相互作用
基本信息
- 批准号:6087471
- 负责人:
- 金额:$ 31.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-15 至 2002-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Integration of a copy of the retroviral genome into cellular DNA is necessary for viral replication, can serve as a model for other recombination events, and offers an attractive target for specific antiviral therapy. To mediate integration in vivo, the integrase protein must catalyze two endonuclease reactions. In both cases, the nucleophilic oxygen of an OH group attacks and joins to target DNA. However, the reactions exhibit dramatically different specificities: one uses diverse nucleophiles and a single target site on viral DNA, the other uses one specific nucleophile and almost any target site on host DNA. The objectives of this plan are to learn how integrase interacts with its various substrates and to establish if perturbing these interactions blocks virus replication. The central hypothesis is that the enzyme s central region has distinct sites for viral DNA, host DNA, and the attacking nucleophilic group. This hypothesis is based on the ability of the isolated central domain to catalyze nonspecific alcoholysis (a recently discovered activity that mimics the enzyme s biological actions), which proved that this domain interacts with nucleophiles and nonviral DNA. Moreover, the central region recognizes viral DNA, as revealed by studies of chimeric human immunodeficiency virus type 1/visna virus integrase proteins. The rationale for focusing on substrate recognition sites is that this information will complement structural data to model integration and will identify new antiviral targets. The Specific Aims are to: (1) Understand how integrase interacts with its nucleophilic substrates. The unique perspective of the nonspecific alcoholysis assay will reveal how the structures of the nucleophile or target and the divalent metal cofactor affect these interactions. In addition, the nucleophile site (which is hypothesized to be near the active site in the middle of the central domain) will be identified by examining these interactions using proteins with specific amino acid substitutions. (2) Understand how integrase interacts with its target DNA substrates. Assays of new chimeric integrases will localize the viral DNA site (which is hypothesized to be in the C-terminal portion of the central domain) and the host DNA site (which is hypothesized to be in the N-terminal portion of the central domain). (3) Establish whether interfering with the interactions between integrase and its various substrates is a viable antiviral strategy. Integrase mutations that do not abolish activity but affect nucleophile choice, viral DNA specificity, or target-site selection will be placed into viruses to test the hypothesis that these interactions are rate-limiting for virus replication, i.e., that partial interference will inhibit replication.
将逆转录病毒基因组的拷贝整合到细胞DNA中对于病毒复制是必需的,可以作为其他重组事件的模型,并且为特异性抗病毒治疗提供了有吸引力的靶标。 为了介导体内整合,整合酶蛋白必须催化两个核酸内切酶反应。 在这两种情况下,OH基团的亲核氧攻击并连接到靶DNA。 然而,这些反应表现出显着不同的特异性:一种使用不同的亲核试剂和病毒DNA上的单个靶位点,另一种使用一种特定的亲核试剂和宿主DNA上的几乎任何靶位点。 本计划的目标是了解整合酶如何与其各种底物相互作用,并确定干扰这些相互作用是否会阻止病毒复制。 核心假设是,酶的中心区域有不同的位点,病毒DNA,宿主DNA和攻击亲核基团。 这一假设是基于分离的中心结构域催化非特异性醇解的能力(最近发现的一种模拟酶生物学作用的活性),这证明了该结构域与亲核试剂和非病毒DNA相互作用。 此外,中心区域识别病毒DNA,如嵌合人类免疫缺陷病毒1型/visna病毒整合酶蛋白的研究所揭示的。 关注底物识别位点的基本原理是,这些信息将补充结构数据以建立模型整合,并将鉴定新的抗病毒靶点。 具体目的是:(1)了解整合酶与其亲核底物的相互作用。 非特异性醇解分析的独特视角将揭示亲核试剂或靶点的结构和二价金属辅因子如何影响这些相互作用。 此外,将通过使用具有特定氨基酸取代的蛋白质检查这些相互作用来鉴定亲核位点(假设其靠近中心结构域中间的活性位点)。 (2)了解整合酶如何与其靶DNA底物相互作用。 新嵌合整合酶的测定将定位病毒DNA位点(假设其位于中心结构域的C-末端部分)和宿主DNA位点(假设其位于中心结构域的N-末端部分)。 (3)确定干扰整合酶及其各种底物之间的相互作用是否是一种可行的抗病毒策略。 不会消除活性但影响亲核选择、病毒DNA特异性或靶位点选择的整合酶突变将被置于病毒中,以测试这些相互作用限制病毒复制速率的假设,即,部分干扰会抑制复制
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Activity of HIV-1 integrases recovered from subjects with varied rates of disease progression.
从疾病进展速度不同的受试者中恢复了 HIV-1 整合酶的活性。
- DOI:10.1097/00042560-200111010-00001
- 发表时间:2001
- 期刊:
- 影响因子:0
- 作者:Katzman,M;Harper,AL;Sudol,M;Skinner,LM;Eyster,ME
- 通讯作者:Eyster,ME
Nucleophile selection for the endonuclease activities of human, ovine, and avian retroviral integrases.
人类、绵羊和禽类逆转录病毒整合酶核酸内切酶活性的亲核体选择。
- DOI:10.1074/jbc.m007032200
- 发表时间:2001
- 期刊:
- 影响因子:0
- 作者:Skinner,LM;Sudol,M;Harper,AL;Katzman,M
- 通讯作者:Katzman,M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL KATZMAN其他文献
MICHAEL KATZMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL KATZMAN', 18)}}的其他基金
Novel Stimulators of HIV-1 Integrase for Use in Combination Microbicide Regimens
用于组合杀微生物剂方案的新型 HIV-1 整合酶刺激剂
- 批准号:
7846492 - 财政年份:2009
- 资助金额:
$ 31.02万 - 项目类别:
Novel Stimulators of HIV-1 Integrase for Use in Combination Microbicide Regimens
用于组合杀微生物剂方案的新型 HIV-1 整合酶刺激剂
- 批准号:
7335549 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
Novel Stimulators of HIV-1 Integrase for Use in Combination Microbicide Regimens
用于组合杀微生物剂方案的新型 HIV-1 整合酶刺激剂
- 批准号:
7500706 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
相似国自然基金
Lentivirus载体转染骨髓间质干细胞诱导增殖和成骨细胞定向分化修复骨缺损的研究
- 批准号:30371434
- 批准年份:2003
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
Improving the production and quality of lentivirus for the transduction of haematopoeitic stem cells via a perfusion culture process
通过灌注培养过程提高用于转导造血干细胞的慢病毒的产量和质量
- 批准号:
2734111 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
Studentship
Lentivirus Rev protein: characterization and study of Rev - nucleolar protein interactions
慢病毒 Rev 蛋白:Rev - 核仁蛋白相互作用的表征和研究
- 批准号:
RGPIN-2016-06532 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
Discovery Grants Program - Individual
Lentivirus-like particle specific delivery of Cas12 ribonucleoprotein (RNP) to HIV reservoir cells in vivo for an HIV cure
慢病毒样颗粒将 Cas12 核糖核蛋白 (RNP) 特异性递送至体内 HIV 储存细胞以治疗 HIV
- 批准号:
10598912 - 财政年份:2022
- 资助金额:
$ 31.02万 - 项目类别:
Improving the production and quality of lentivirus for the transduction of haematopoeitic stem cells via a perfusion culture process
通过灌注培养过程提高用于转导造血干细胞的慢病毒的产量和质量
- 批准号:
2585771 - 财政年份:2021
- 资助金额:
$ 31.02万 - 项目类别:
Studentship
Lentivirus Rev protein: characterization and study of Rev - nucleolar protein interactions
慢病毒 Rev 蛋白:Rev - 核仁蛋白相互作用的表征和研究
- 批准号:
RGPIN-2016-06532 - 财政年份:2020
- 资助金额:
$ 31.02万 - 项目类别:
Discovery Grants Program - Individual
Repertoire-scale T cell antigen identification via peptide-MHC lentivirus display
通过肽-MHC 慢病毒展示进行全库规模 T 细胞抗原鉴定
- 批准号:
10001123 - 财政年份:2020
- 资助金额:
$ 31.02万 - 项目类别:
Lentivirus persistence in the brain: viral, host and therapeutic determinants
慢病毒在大脑中的持久性:病毒、宿主和治疗决定因素
- 批准号:
401955 - 财政年份:2019
- 资助金额:
$ 31.02万 - 项目类别:
Operating Grants
Development of a scalable and consistent process for the production of lentivirus for gene-modified cell therapies
开发用于基因修饰细胞疗法的慢病毒生产的可扩展且一致的工艺
- 批准号:
2246819 - 财政年份:2019
- 资助金额:
$ 31.02万 - 项目类别:
Studentship
Lentivirus Replication Strategy and Pathogenesis
慢病毒复制策略和发病机制
- 批准号:
10700321 - 财政年份:2018
- 资助金额:
$ 31.02万 - 项目类别: